#jak inhibitor — Thursday, May 14, 2026 (1 items)
| 0 | 💬 0 |
A Phase 3 Trial of Brepocitinib in Dermatomyositis.
(nejm.org)
|
New England Journal of Medicine 2026-05-14 | #inflammation #immunosuppression #dermatomyositis #clinical trial #jak inhibitor |